Global Information
회사소개 | 문의 | 비교리스트

세계의 인공호흡기 시장 : 분석과 예측(2021-2030년)

Global Ventilator Market : Analysis and Forecast, 2021-2030

리서치사 BIS Research Inc.
발행일 2020년 06월 상품 코드 941001
페이지 정보 영문
가격
US $ 5,000 ₩ 6,078,000 Unprintable PDF by E-mail (Single User License)
US $ 5,500 ₩ 6,685,000 Hard Copy
US $ 6,500 ₩ 7,901,000 Printable PDF by E-mail (Single Site License)
US $ 8,000 ₩ 9,724,000 Printable PDF and Excel by E-mail (Enterprise-wide License)


세계의 인공호흡기 시장 : 분석과 예측(2021-2030년) Global Ventilator Market : Analysis and Forecast, 2021-2030
발행일 : 2020년 06월 페이지 정보 : 영문

세계 인공호흡기 시장은 COVID-19 팬데믹에 의해 시장 규모가 급속하게 확대되고 있습니다. COVID-19 팬데믹 이전 시나리오에서 예측기간 동안 7.1%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측되고 있었지만, COVID-19 팬데믹에 의해 2020년 성장률이 최대 172% 증가할 것으로 전망되고 있습니다.

세계의 인공호흡기(Ventilator) 시장에 대해 조사했으며, 업계 동향, 시장 기회 및 점유율, 성장 촉진요인 및 억제요인, 제품 유형·모달리티·환자 연령·최종사용자·지역별 시장 분석, 경쟁 상황, 주요 기업 프로파일 등의 정보를 제공합니다.

목차

개요

제1장 제품의 정의

제2장 조사 범위

제3장 보고서 조사 방법

제4장 시장 개요

  • 인공호흡기 개요
  • 세계의 인공호흡기 설치 거점
  • 세계의 인공호흡기 시장 시나리오

제5장 경쟁 분석

  • 시장 점유율 분석
    • 세계의 인공호흡기 시장 점유율 분석
    • 세계의 비침습적 인공호흡기 시장 점유율 분석
  • 제품 매핑 분석
  • 주요 전략 및 개발
  • 시장 진출기업의 유형
  • 기업의 기회와 과제
  • 가격 분석

제6장 산업 분석

  • 특허 분석
  • 규제 프레임워크와 정부 이니셔티브
    • COVID-19 이전과 COVID-19 이후 규제 비교
    • 긴급사용승인(EUA)
  • 수급 분석
    • 세계 수급
    • 컴포넌트 공급망
    • 인공호흡기 비용 심층 분석

제7장 세계의 인공호흡기 시장 규모 예측

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
  • 영향 분석
  • 성장 기회
    • 코로나바이러스 대유행에 따른 수요
    • 가정간호 및 비상 휴대용 인공호흡기의 요건 증가
    • 디지털 교육 및 트레이닝 툴 개발

제8장 시장 분석 : 제품 유형별

  • 중환자용 인공호흡기
  • 휴대용 인공호흡기

제9장 시장 분석 : 모달리티별

  • 비침습적 인공호흡기
  • 침습적 인공호흡기/기계적 인공호흡기

제10장 시장 분석 : 환자 연령별

  • 소아/신생아
  • 성인

제11장 시장 분석 : 최종사용자별

  • 병원/전문 클리닉
  • 응급 의료 서비스
  • 홈케어

제12장 시장 분석 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타

제13장 기업 개요

  • Aerobiosys Innovations Private Limited
  • Air Liquide
  • Dragerwerk AG & Co. KGaA
  • General Electric Company
  • Getinge AB
  • Hamilton Medical
  • Koninklijke Philips NV
  • Lowenstein Medical Innovation GmbH & Co. KG
  • Medtronic plc
  • OneBreath Inc.
  • Penlon Ltd
  • ResMed
  • SCHILLER
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smiths Group plc
  • Ventec Life Systems
  • Ventinova Medical
  • VYAIRE MEDICAL, INC.
  • WEINMANN Emergency Medical Technology GmbH Co. KG
  • ZOLL Medical Corporation
  • 비의료 기업
    • Dyson Ltd.
    • Ford Motor Company
    • General Motors Company
    • Maruti Suzuki India Limited
    • Virgin Orbit (Subsidiary of Virgin Group)
LSH 20.06.29

“Global Ventilator Market to Reach $3,110 Million by the End of 2020 Due to COVID-19 Pandemic.”

Market Segmentation

  • Product Type - Intensive Care Ventilator and Portable Ventilator
  • Modality - Invasive Ventilation and Non-Invasive Ventilation
  • Patient Age- Adult and Pediatric and Neonates
  • End User - Hospitals and Specialty Clinics, Emergency Medical Services, and Homecare

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, South Korea, Singapore, Australia and New Zealand, Rest-of-Asia-Pacific
  • Rest-of-the-World - Latin America, Middle East and Africa

Growth Drivers

  • Increasing Respiratory Disease Incidences
  • Rising Geriatric Population
  • Increase in Number of ICU Beds
  • High Number of Premature Births
  • Government and Organizational Initiatives to Boost Ventilator Production

Market Challenges

  • Complications and Side-Effects Associated with Ventilator Usage
  • Lack of Trained Medical Staff

Market Opportunities

  • Coronavirus Outbreak Leading to Rising Global Ventilator Demand
  • Increasing Requirement of Portable Ventilators for Homecare and Emergency Usage
  • Development of Digital Education and Training Tool

Key Healthcare and Non-Healthcare Companies Profiled

Aerobiosys Innovations Private Limited, Air Liquide, Dragerwerk AG & Co. KGaA, General Electric Company, Getting AB, Hamilton Medical, Koninklijke Philips N.V., Lowenstein Medical Innovation GmbH & Co. KG, Medtronic plc, OneBreath Inc., Penlon Ltd, ResMed, SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Smiths Group plc, Ventec Life Systems, Ventinova Medical, VYAIRE MEDICAL,INC., WEINMANN Emergency Medical Technology GmbH + Co. KG, ZOLL Medical Corporation

Non-Healthcare Companies

Dyson Ltd, Ford Motor Company, General Motors Company, Maruti Suzuki India Limited, Virgin Orbit

Key Questions Answered:

  • What are the product types offered by the key players within the global ventilator market?
  • What was the total installed base of ventilators, by country, in 2019?
  • What is the change witnessed in the growth rate of the global ventilator market from pre-COVID to post-COVID scenario?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • What are the strategies opted by the healthcare and non-healthcare companies amidst coronavirus pandemic to meet the high demand for ventilators?
  • What are the opportunities and challenges faced by healthcare and non-healthcare companies within the global ventilator market?
  • What was the market share of each of the companies in mechanical ventilator and non-invasive ventilator segments of the global ventilator market in 2019?
  • What are the pricing trends of ventilators in the last five years?
  • What are the major regulatory changes taking place in the global ventilator market pre-COVID-19, during COVID-19, and post-COVID-19? How are these changes expected to impact the global ventilator market in the future?
  • How is the industry expected to evolve during the forecast period, 2021-2030?
  • What will be the impact on the products that have been awarded emergency use authorization (EUA) during the COVID-19 pandemic, once the pandemic is over?
  • How has the supply and demand of the ventilator changed during the COVID-19 phase in contrast to the pre-COVID-19 phase?
  • What is the market value estimates of the leading segments of the global ventilator market in 2030?
  • What is the change witnessed in the growth rate of the global ventilator market from pre-COVID to post-COVID scenario?
  • What are the major driving factors, challenges, and opportunities for the global ventilator market? What will be the impact of these factors once the COVID-19 pandemic is over?
  • What is the growth potential of the global ventilator market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What impact of large ventilator inventories on the global ventilator market is expected once the COVID-19 pandemic is over?

Market Overview

The global ventilator market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $1,072 million in FY 2018, and it was expected to grow at a CAGR of 7.1% in the pre-COVID scenario. However, the COVID-19 pandemic has resulted in an extensive rise in the ventilator demand and has increased the growth rate by up to 172% in 2020. Presently, more than 45 companies are operating in this market, including already exiting healthcare companies and emerging non-healthcare companies. The maximum number of installed ventilators are in the U.S., followed by China and India. However, there is still a requirement for an additional 85,000 ventilators to cope with the COVID-19 pandemic. This demand and supply deficit of ventilators worldwide has led to major changes within the dynamics of the global ventilator market.

Moreover, to cope with the rising demand for ventilators, regulatory bodies across different regions, such as the Food and Drug Administration (FDA), Health Canada, and Therapeutics Goods Administration (TGA), have taken unprecedented steps. For instance, in March 2020 FDA declared COVID-19 pandemic as a public emergency and authorized anesthesia gas machines, continuous positive airway pressure (CPAP), and other sleep apnea devices as alternative ventilators under emergency use authorization (EUA). Furthermore, in April 2020, the TGA published a document stating the minimum requirements to be met by medical devices to be used as alternative ventilators.

Our healthcare experts are continuously analyzing the impact of regulatory and industrial decisions on the global ventilator market. The market is driven by certain factors, which include the rising incidence of respiratory diseases, high rate of premature births, rising demand for critical care in the geriatric population, and government initiatives for boosting the ventilator production.

The market is favored by the development of low-cost ventilator products and partnerships between healthcare and non-healthcare companies for scaling up the ventilator production.

Within the research report, the market is segmented based on product type, modality, patient age, end user and regional analysis. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Table of Contents

Executive Summary

1 Product Definition

2 Research Scope

  • 2.1 Research Scope
  • 2.2 Exclusion Criteria of the Report
  • 2.3 Key Questions Answered by the Research Study

3 Report Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Market Estimation Model
  • 3.4 Data Sources Categorization
  • 3.5 Selection Criteria for Company Profiles
  • 3.6 Assumptions and Limitations

4 Market Overview

  • 4.1 Overview of Ventilators
  • 4.2 Global Installed Base of the Ventilators
  • 4.3 Global Ventilator Market Scenario

5 Competitive Analysis

  • 5.1 Market Share Analysis
    • 5.1.1 Market Share Analysis for the Global Mechanical Ventilators Market
    • 5.1.2 Market Share Analysis for the Global Non-Invasive Ventilators Market
  • 5.2 Product Mapping Analysis
  • 5.3 Key Strategies and Developments
    • 5.3.1 Product Approvals and Launches
    • 5.3.2 Synergistic Activities (Joint Ventures, Collaborations, and Partnerships)
    • 5.3.3 Funding
    • 5.3.4 Product Upgradation and Corrective Actions
    • 5.3.5 Acquisitions
  • 5.4 Types of Company Entering the Market
    • 5.4.1 Healthcare Companies
    • 5.4.2 Non-Healthcare Companies
  • 5.5 Opportunities and Challenges for Companies
    • 5.5.1 Healthcare Companies
    • 5.5.2 Non-Healthcare Companies
  • 5.6 Pricing Analysis

6 Industry Analysis

  • 6.1 Patent Analysis
    • 6.1.1 Patent Filling Trend, Pre-COVID Phase (January 2015-March 2020)
  • 6.2 Regulatory Framework and Government Initiatives
    • 6.2.1 Comparison of the Pre-COVID-19 and Post-COVID-19 Regulations
      • 6.2.1.1 Regulations in North America
        • 6.2.1.1.1 Food and Drug Administration (FDA)
        • 6.2.1.1.2 Health Canada
      • 6.2.1.2 Regulations in Europe
      • 6.2.1.3 Regulations in Asia-Pacific
        • 6.2.1.3.1 National Medical Products Administration (NMPA)
        • 6.2.1.3.2 Pharmaceutical and Medical Device Agency (PMDA)
        • 6.2.1.3.3 The Central Drug Standard Control Organization (CDSCO)
        • 6.2.1.3.4 Therapeutic Goods Administration (TGA)
        • 6.2.1.3.5 Health Science Authority (HSA)
      • 6.2.1.4 Regulations in Latin America
    • 6.2.2 Emergency Use Authorization (EUA)
  • 6.3 Supply and Demand Analysis
    • 6.3.1 Global Supply and Demand
      • 6.3.1.1 Pre-COVID
      • 6.3.1.2 Post-COVID
    • 6.3.2 Component Supply Chain
    • 6.3.3 Tear-Down Analysis of Ventilator Costing

7 Global Ventilator Market Sizing and Forecast

  • 7.1 Market Dynamics
    • 7.1.1 Growth Promoting Factors
      • 7.1.1.1 Increasing Respiratory Disease Incidences
      • 7.1.1.2 Rising Geriatric Population
      • 7.1.1.3 Increase in Number of ICU Beds
      • 7.1.1.4 High Number of Premature Births
      • 7.1.1.5 Government and Organizational Initiatives to Boost Ventilator Production
    • 7.1.2 Growth Inhibiting Factors
      • 7.1.2.1 Complications and Side-Effects Associated with Ventilators Usage
      • 7.1.2.2 Lack of Trained Medical Staff
  • 7.2 Impact Analysis
  • 7.3 Growth Opportunities
    • 7.3.1 Coronavirus Outbreak Leading to Rising Global Ventilator Demand
    • 7.3.2 Increasing Requirement of Portable Ventilators for Homecare and Emergency Usage
    • 7.3.3 Development of Digital Education and Training Tool

8 Global Ventilator Market (by Product Type)

  • 8.1 Intensive Care Ventilator
  • 8.2 Portable Ventilator

9 Global Ventilator Market (by Modality)

  • 9.1 Non-Invasive Ventilation
  • 9.2 Invasive Ventilation/Mechanical Ventilation

10 Global Ventilator Market (by Patient Age)

  • 10.1 Pediatric and Neonates
  • 10.2 Adult

11 Global Ventilator Market (by End User)

  • 11.1 Hospitals and Specialty Clinics
  • 11.2 Emergency Medical Services
  • 11.3 Homecare

12 Global Ventilator Market (by Region)

  • 12.1 North America Ventilator Market
    • 12.1.1 North America Ventilator Market (by Product Type)
    • 12.1.2 North America Ventilator Market (by Modality)
    • 12.1.3 North America Ventilator Market (by Patient Age)
    • 12.1.4 North America Ventilator Market (by End User)
    • 12.1.5 North America Ventilator Market (by Country)
      • 12.1.5.1 U.S.
        • 12.1.5.1.1 U.S. Ventilator Market (by Product Type)
        • 12.1.5.1.2 U.S. Ventilator Market (by Modality)
        • 12.1.5.1.3 U.S. Ventilator Market (by Patient Age)
        • 12.1.5.1.4 U.S. Ventilator Market (by End User)
      • 12.1.5.2 Canada
        • 12.1.5.2.1 Canada Ventilator Market (by Product Type)
        • 12.1.5.2.2 Canada Ventilator Market (by Modality)
        • 12.1.5.2.3 Canada Ventilator Market (by Patient Age)
        • 12.1.5.2.4 Canada Ventilator Market (by End User)
  • 12.2 Europe Ventilator Market
    • 12.2.1 Europe Ventilator Market (by Product Type)
    • 12.2.2 Europe Ventilator Market (by Modality)
    • 12.2.3 Europe Ventilator Market (by Patient Age)
    • 12.2.4 Europe Ventilator Market (by End User)
    • 12.2.5 Europe Ventilator Market (by Country)
      • 12.2.5.1 Germany
        • 12.2.5.1.1 Germany Ventilator Market (by Product Type)
        • 12.2.5.1.2 Germany Ventilator Market (by Modality)
        • 12.2.5.1.3 Germany Ventilator Market (by Patient Age)
        • 12.2.5.1.4 Germany Ventilator Market (by End User)
      • 12.2.5.2 The U.K.
        • 12.2.5.2.1 The U.K. Ventilator Market (by Product Type)
        • 12.2.5.2.2 The U.K. Ventilator Market (by Modality)
        • 12.2.5.2.3 The U.K. Ventilator Market (by Patient Age)
        • 12.2.5.2.4 The U.K. Ventilator Market (by End User)
      • 12.2.5.3 France
        • 12.2.5.3.1 France Ventilator Market (by Product Type)
        • 12.2.5.3.2 France Ventilator Market (by Modality)
        • 12.2.5.3.3 France Ventilator Market (by Patient Age)
        • 12.2.5.3.4 France Ventilator Market (by End User)
      • 12.2.5.4 Italy
        • 12.2.5.4.1 Italy Ventilator Market (by Product Type)
        • 12.2.5.4.2 Italy Ventilator Market (by Modality)
        • 12.2.5.4.3 Italy Ventilator Market by (Patient Age)
        • 12.2.5.4.4 Italy Ventilator Market (by End User)
      • 12.2.5.5 Spain
        • 12.2.5.5.1 Spain Ventilator Market (by Product Type)
        • 12.2.5.5.2 Spain Ventilator Market (by Modality)
        • 12.2.5.5.3 Spain Ventilator Market (By Patient Age)
        • 12.2.5.5.4 Spain Ventilator Market (by End User)
      • 12.2.5.6 Rest-of-Europe
        • 12.2.5.6.1 Rest-of-Europe Ventilator Market (by Product Type)
        • 12.2.5.6.2 Rest-of-Europe Ventilator Market (by Modality)
        • 12.2.5.6.3 Rest-of-Europe Ventilator Market (by Patient Age)
        • 12.2.5.6.4 Rest-of-Europe Ventilator Market (by End User)
  • 12.3 Asia-Pacific Ventilator Market
    • 12.3.1 Asia-Pacific Ventilator Market (by Product Type)
    • 12.3.2 Asia-Pacific Ventilator Market (by Modality)
    • 12.3.3 Asia-Pacific Ventilator Market (by Patient Age)
    • 12.3.4 Asia-Pacific Ventilator Market (by End User)
    • 12.3.5 Asia-Pacific Ventilator Market, (by Country)
      • 12.3.5.1 China
        • 12.3.5.1.1 China Ventilator Market (by Product Type)
        • 12.3.5.1.2 China Ventilator Market (by Modality)
        • 12.3.5.1.3 China Ventilator Market (by Patient Age)
        • 12.3.5.1.4 China Ventilator Market (by End User)
      • 12.3.5.2 Japan
        • 12.3.5.2.1 Japan Ventilator Market (by Product Type)
        • 12.3.5.2.2 Japan Ventilator Market (by Modality)
        • 12.3.5.2.3 Japan Ventilator Market (by Patient Age)
        • 12.3.5.2.4 Japan Ventilator Market (by End User)
      • 12.3.5.3 India
        • 12.3.5.3.1 India Ventilator Market (by Product Type)
        • 12.3.5.3.2 India Ventilator Market (by Modality)
        • 12.3.5.3.3 India Ventilator Market (by Patient Age)
        • 12.3.5.3.4 India Ventilator Market (by End User)
      • 12.3.5.4 South Korea
        • 12.3.5.4.1 South Korea Ventilator Market (by Product Type)
        • 12.3.5.4.2 South Korea Ventilator Market (by Modality)
        • 12.3.5.4.3 South Korea Ventilator Market (by Patient Age)
        • 12.3.5.4.4 South Korea Ventilator Market (by End User)
      • 12.3.5.5 Singapore
        • 12.3.5.5.1 Singapore Ventilator Market (by Product Type)
        • 12.3.5.5.2 Singapore Ventilator Market (by Modality)
        • 12.3.5.5.3 Singapore Ventilator Market (by Patient Age)
        • 12.3.5.5.4 Singapore Ventilator Market (by End User)
      • 12.3.5.6 Australia and New Zealand
        • 12.3.5.6.1 Australia and New Zealand Ventilator Market (by Product Type)
        • 12.3.5.6.2 Australia and New Zealand Ventilator Market (by Modality)
        • 12.3.5.6.3 Australia and New Zealand Ventilator Market (by Patient Age)
        • 12.3.5.6.4 Australia and New Zealand Ventilator Market (by End User)
      • 12.3.5.7 Rest-of-Asia-Pacific
        • 12.3.5.7.1 Rest-of-Asia-Pacific Ventilator Market (by Product Type)
        • 12.3.5.7.2 Rest- of -Asia-Pacific Ventilator Market (by Modality)
        • 12.3.5.7.3 Rest-of-Asia-Pacific Ventilator Market (by Patient Age)
        • 12.3.5.7.4 Rest-of-Asia-Pacific Ventilator Market (by End User)
  • 12.4 Rest-of-the-World Ventilator Market
    • 12.4.1 Rest-of-the-World Ventilator Market (by Product Type)
    • 12.4.2 Rest-of-the-World Ventilator Market (by Modality)
    • 12.4.3 Rest-of-the-World Ventilator Market (by Patient Age)
    • 12.4.4 Rest-of-the-World Ventilator Market (by End User)

13 Company Profiles

  • 13.1 Aerobiosys Innovations Private Limited
    • 13.1.1 Company Overview
    • 13.1.2 Role of Aerobiosys Innovations Private Limited in the Global Ventilator Market
    • 13.1.3 Aerobiosys Innovations Private Limited in the COVID-19 Scenario
  • 13.2 Air Liquide
    • 13.2.1 Company Overview
    • 13.2.2 Role of Air Liquide in the Global Ventilator Market
    • 13.2.3 Recent Developments
    • 13.2.4 Air Liquide Healthcare in the COVID-19 Scenario
  • 13.3 Dragerwerk AG & Co. KGaA
    • 13.3.1 Company Overview
    • 13.3.2 Role of Dragerwerk AG & Co. KGaA in the Global Ventilator Market
    • 13.3.3 Recent Developments
    • 13.3.4 Dragerwerk AG & Co. KGaA in the COVID-19 Scenario
  • 13.4 General Electric Company
    • 13.4.1 Company Overview
    • 13.4.2 Role of General Electric Company in the Global Ventilator Market
    • 13.4.3 Recent Developments
    • 13.4.4 GE Healthcare in the COVID-19 Scenario
  • 13.5 Getinge AB
    • 13.5.1 Company Overview
    • 13.5.2 Role of Getinge AB in the Global Ventilator Market
    • 13.5.3 Recent Developments
    • 13.5.4 Getinge AB in the COVID-19 Scenario
  • 13.6 Hamilton Medical
    • 13.6.1 Company Overview
    • 13.6.2 Role of Hamilton Medical in the Global Ventilator Market
    • 13.6.3 Recent Developments
    • 13.6.4 Hamilton Medical in the COVID-19 Scenario
  • 13.7 Koninklijke Philips N.V
    • 13.7.1 Company Overview
    • 13.7.2 Role of Koninklijke Philips N.V.in the Global Ventilator Market
    • 13.7.3 Recent Developments
    • 13.7.4 Koninklijke Philips N.V. in the COVID-19 Scenario
  • 13.8 Lowenstein Medical Innovation GmbH & Co. KG
    • 13.8.1 Company Overview
    • 13.8.2 Role of Lowenstein Medical Innovation GmbH & Co. KG in the Global Ventilator Market
    • 13.8.3 Recent Development
    • 13.8.4 Lowenstein Medical Innovation GmbH & Co. KG in the COVID-19 Scenario
  • 13.9 Medtronic plc
    • 13.9.1 Company Overview
    • 13.9.2 Role of Medtronic plc in the Global Ventilator Market
    • 13.9.3 Recent Developments
    • 13.9.4 Medtronic plc in the COVID-19 Scenario
  • 13.10 OneBreath Inc.
    • 13.10.1 Company Overview
    • 13.10.2 Role of OneBreath Inc. in the Global Ventilator Market
    • 13.10.3 Recent Developments
    • 13.10.4 OneBreath Inc. in the COVID-19 Scenario
  • 13.11 Penlon Ltd
    • 13.11.1 Company Overview
    • 13.11.2 Role of Penlon Ltd in the Global Ventilator Market
    • 13.11.3 Recent Developments
    • 13.11.4 Penlon Ltd in the COVID-19 Scenario
  • 13.12 ResMed
    • 13.12.1 Company Overview
    • 13.12.2 Role of ResMed. in the Global Ventilator Market
    • 13.12.3 Recent Developments
    • 13.12.4 ResMed in the COVID-19 Scenario
  • 13.13 SCHILLER
    • 13.13.1 Company Overview
    • 13.13.2 Role of SCHILLER in the Global Ventilator Market
  • 13.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 13.14.1 Company Overview
    • 13.14.2 Role of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. in the Global Ventilator Market
    • 13.14.3 Recent Developments
    • 13.14.4 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • 13.15 Smiths Group plc
    • 13.15.1 Company Overview
    • 13.15.2 Role of Smiths Group plc in the Global Ventilator Market
    • 13.15.3 Smiths Medical, Inc. in the COVID-19 Scenario
  • 13.16 Ventec Life Systems
    • 13.16.1 Company Overview
    • 13.16.2 Role of Ventec Life Systems in the Global Ventilator Market
    • 13.16.3 Recent Developments
    • 13.16.4 Ventec Life Systems in the COVID-19 Scenario
  • 13.17 Ventinova Medical
    • 13.17.1 Company Overview
    • 13.17.2 Role of Ventinova Medical in the Global Ventilator Market
    • 13.17.3 Recent Developments
    • 13.17.4 Ventinova Medical in the COVID-19 Scenario
  • 13.18 VYAIRE MEDICAL, INC.
    • 13.18.1 Company Overview
    • 13.18.2 Role of VYAIRE MEDICAL, INC. in the Global Ventilator Market
    • 13.18.3 Recent Developments
    • 13.18.4 VYAIRE MEDICAL, INC. in the COVID-19 Scenario
  • 13.19 WEINMANN Emergency Medical Technology GmbH + Co. KG
    • 13.19.1 Company Overview
    • 13.19.2 Role of WEINMANN Emergency Medical Technology GmbH + Co. KG in the Global Ventilator Market
    • 13.19.3 Recent Developments
    • 13.19.4 WEINMANN Emergency Medical Technology GmbH + Co. KG in the COVID-19 Scenario
  • 13.20 ZOLL Medical Corporation
    • 13.20.1 Company Overview
    • 13.20.2 Role of ZOLL Medical Corporation in the Global Ventilator Market
    • 13.20.3 Recent Developments:
    • 13.20.4 ZOLL Medical Corporation in the COVID-19 Scenario
  • 13.21 Non-Healthcare Companies
    • 13.21.1 Dyson Ltd.
      • 13.21.1.1 Company Overview
      • 13.21.1.2 Role of Dyson Ltd. in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.2 Ford Motor Company
      • 13.21.2.1 Company Overview
      • 13.21.2.2 Role of Ford Motor Company in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.3 General Motors Company
      • 13.21.3.1 Company Overview
      • 13.21.3.2 Role of General Motor Company in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.4 Maruti Suzuki India Limited
      • 13.21.4.1 Company Overview
      • 13.21.4.2 Role of Maruti Suzuki India Limited in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.5 Virgin Orbit (Subsidiary of Virgin Group)
      • 13.21.5.1 Company Overview
      • 13.21.5.2 Role of Virgin Orbit in Global Ventilator Market in the COVID-19 Scenario
Back to Top
전화 문의
F A Q